Viewing Study NCT00340834


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-02-26 @ 10:51 PM
Study NCT ID: NCT00340834
Status: COMPLETED
Last Update Posted: 2017-09-21
First Post: 2006-06-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None FTY720 View
None Interferon View
None RRMS View
None Multiple Sclerosis View
None Efficacy View